Table 1.
Participant’s Characteristics
| Demographic Characteristics |
Control n (%) | Intervention n (%) |
|---|---|---|
| Sex | ||
| Male | 14 (46.7) | 21 (70) |
| Female | 16 (53.3) | 9 (30) |
| Age (years old) | ||
| 2-4 | 10 (33.3) | 9 (30) |
| 5-7 | 4 (13.3) | 5 (16.7) |
| 8-12 | 10 (33.3) | 8 (26.7) |
| 13-18 | 6 (20) | 8 (26.7) |
| Diagnosis | ||
| Lymphoma | 1 (3.5) | 1 (3.5) |
| Solid tumor | 17 (58.6) | 12 (37.9) |
| Leukemia | 12 (37.9) | 17 (58.6) |
| Disease duration | ||
| < 1 year | 21 (70) | 19 (63.3) |
| ≥ 1 year | 9 (30) | 11 (36.7) |
| End-of-life | ||
| Yes | 5 (16.7) | 5 (16.7) |
| No | 25 (83.3) | 25 (83.3) |
| Ongoing chemotherapy | ||
| Yes | 28 (93.3) | 25 (83.3) |
| No | 2 (6.7) | 5 (16.7) |
| Initial ESAS | Mean (SD) | Mean (SD) |
| Pain | 2.43 (1.92) | 3.2 (2.62) |
| Sleep disturbances | 2.07 (1.84) | 2.03 (2.22) |
| Anorexia | 4.70 (1.86) | 3.63 (2.22) |
| Karnofsky score | 75 (14.80) | 75.17 (19.2) |
| Quality of life score | ||
| Pain | 63.70 (32.14) | 65.83 (24.7) |
| Nausea | 61.33 (24.39) | 62.07 (23.2) |
| Procedure anxiety | 40.03 (31.81) | 46.55 (34.5) |
| Treatment anxiety | 66.70 (30.06) | 73.28 (24.8) |
| Worry | 74.70 (21.82) | 71.28 (27.1) |
| Physique | 79.47 (33.92) | 83.97 (22.2) |
| Cognitive | 75.17 (22.41) | 66.10 (19.5) |
| Total | 65.64 (16.47) | 65.45 (14.6) |